Market Cap
474531968.00
TBPH
Theravance Biopharma, Inc.
Exchange: nyse
Multiples
- P/E: -9.61
- P/BV: 2.55
- P/TBV: 2.23
Description:
TBPH is the ticker symbol for Tocagen Inc., a biopharmaceutical company that was listed on the New York Stock Exchange (NYSE) until it delisted in 2020 due to its merger activities and subsequent restructuring. Tocagen was known for developing cancer therapies based on its proprietary platform technology designed to activate a patient's immune system against cancer cells. The company aimed to provide innovative treatment options for patients suffering from various forms of cancer, focusing particularly on brain tumors and other solid tumors where there was a significant unmet medical need.
Data:
Yields:
Earnings Yield
0.756010900338
Return on Capital
-0.605076591974
CAGR (net income)
0%
CAGR Length
0
Dividend Rate
